DNA, D(3'-AMINO-3'-DEOXY-P-THIO)(T-A-G-G-G-T-T-A-G-A-C-A-A), 5'-(O-(2-HYDROXY-3-((1-OXOHEXADECYL)AMINO)PROPYL) HYDROGEN PHOSPHOROTHIOATE)
Anaplastic Ependymoma
Pediatric Brain Tumor Consortiumnucleic_acidPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Anaplastic Ependymoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Lopinavir Case Comprehensive Cancer Center | Phase 2 | CCC |
RITONAVIR Case Comprehensive Cancer Center | Phase 2 | CCC |
axl1717 Rush University Medical Center | Phase 1/2 | CCC |
Ribociclib St. Jude Children's Research Hospital | Phase 1 | CC |
FILGRASTIM St. Jude Children's Research Hospital | Phase 1 | CC |
View all 12 →
Same molecule, other indications
DNA, D(3'-AMINO-3'-DEOXY-P-THIO)(T-A-G-G-G-T-T-A-G-A-C-A-A), 5'-(O-(2-HYDROXY-3-((1-OXOHEXADECYL)AMINO)PROPYL) HYDROGEN PHOSPHOROTHIOATE) is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →